www.fdanews.com/articles/185780-reva-receives-ce-mark-for-fantom-encore-bioresorbable-scaffold
Reva Receives CE Mark for Fantom Encore Bioresorbable Scaffold
February 26, 2018
Reva received a CE mark and reported the first implant of the Fantom Encore bioresorbable scaffold.
Bioresorbable scaffolds were developed as an alternative to metal drug-eluting stents for the treatment of coronary artery disease. The Fantom Encore offers a thin profile without compromising strength or X-ray visibility, using improved polymer processing and manufacturing techniques.
REVA expects to launch the entire Fantom Encore product line later this year.